Literature DB >> 12528099

Selective cyclooxygenase 2 inhibitors, aspirin, and cardiovascular disease: a reappraisal.

Colin Baigent1, Carlo Patrono.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12528099     DOI: 10.1002/art.10738

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


× No keyword cloud information.
  20 in total

Review 1.  Cardiovascular Effects of Nonsteroidal Anti-inflammatory Drugs.

Authors:  Carlo Patrono
Journal:  Curr Cardiol Rep       Date:  2016-03       Impact factor: 2.931

Review 2.  Adventures in vascular biology: a tale of two mediators.

Authors:  S Moncada
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2006-05-29       Impact factor: 6.237

3.  Dominant negative actions of human prostacyclin receptor variant through dimerization: implications for cardiovascular disease.

Authors:  Salam Ibrahim; Mazell Tetruashvily; Alex J Frey; Stephen J Wilson; Jeremiah Stitham; John Hwa; Emer M Smyth
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-06-03       Impact factor: 8.311

Review 4.  Cyclooxygenase-2 inhibition: vascular inflammation and cardiovascular risk.

Authors:  Francesco Cipollone; Maria Luigia Fazia
Journal:  Curr Atheroscler Rep       Date:  2006-05       Impact factor: 5.113

5.  Heterodimerization with the prostacyclin receptor triggers thromboxane receptor relocation to lipid rafts.

Authors:  Salam Ibrahim; Ann McCartney; Nune Markosyan; Emer M Smyth
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-11-15       Impact factor: 8.311

6.  Methyl salicylate lactoside inhibits inflammatory response of fibroblast-like synoviocytes and joint destruction in collagen-induced arthritis in mice.

Authors:  Wenyu Xin; Chao Huang; Xue Zhang; Sheng Xin; Yiming Zhou; Xiaowei Ma; Dan Zhang; Yongjie Li; Sibai Zhou; Dongming Zhang; Tiantai Zhang; Guanhua Du
Journal:  Br J Pharmacol       Date:  2014-07       Impact factor: 8.739

7.  Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials.

Authors:  Patricia M Kearney; Colin Baigent; Jon Godwin; Heather Halls; Jonathan R Emberson; Carlo Patrono
Journal:  BMJ       Date:  2006-06-03

8.  COX-2 chronology.

Authors:  C J Hawkey
Journal:  Gut       Date:  2005-11       Impact factor: 23.059

Review 9.  Aspirin, NSAIDs, and COX-2 inhibitors in cardiovascular disease: possible interactions and implications for treatment of rheumatoid arthritis.

Authors:  Tobias Kurth; Charles H Hennekens; Julie E Buring; J Michael Gaziano
Journal:  Curr Rheumatol Rep       Date:  2004-10       Impact factor: 4.592

10.  Activation-dependent stabilization of the human thromboxane receptor: role of reactive oxygen species.

Authors:  Stephen J Wilson; Claire C Cavanagh; Allison M Lesher; Alexander J Frey; Shane E Russell; Emer M Smyth
Journal:  J Lipid Res       Date:  2009-01-16       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.